CD8A and cancer: Persistent tumour antigen presentation induces chronic LAG3 expression on T-cells within the TME, leading to the impairment of CD8+ T-cell function through a progressive loss of cytokine production and cancer cell killing ability, a phenomenon dubbed T-cell functional ‘exhaustion’ [71].